Best Peptides for Skin: Peptide Ingredients in Skincare Ranked by Evidence

Short answer: The best peptides for skin, by human evidence, are palmitoyl pentapeptide-4 (Matrixyl) and acetyl hexapeptide-8 (Argireline). Peptide ingredients in skincare are short amino-acid chains grouped into 4 classes: signal, carrier, neurotransmitter-inhibiting and enzyme-inhibitor peptides (Gorouhi & Maibach, 2009). Both have only small human trials, and most of the 102 commercial peptides in a 2025 review rely on lab data alone (van Walraven et al., 2025). Evidence: limited.

Key takeaways

• The best-tested peptide is palmitoyl pentapeptide-4: in a 12-week split-face RCT of 93 women it beat placebo on fine lines (Robinson et al., 2005). Evidence: limited (manufacturer-run).
• Argireline reduced wrinkle depth by up to 30% in 30 days in its developers' study (Blanes-Mira et al., 2002) and beat placebo in a 60-person RCT (Wang et al., 2013). How it gets anywhere near a muscle is still unexplained.
• Penetration is the central weak spot. Most peptides are large and water-loving, and the stratum corneum is built to keep exactly those molecules out.
• Peptides are low-irritation and generally combine easily with each other and with other actives, but they are not a substitute for a retinoid or sunscreen.

This is one of two hub guides in our Peptide Science section. For a deep dive on the copper peptide, see our GHK-Cu guide, including how to layer it with retinol and vitamin C.

What are the best peptides for skin, by evidence?

The best peptides for skin, judged by published human trials, are palmitoyl pentapeptide-4 (Matrixyl) for fine lines and acetyl hexapeptide-8 (Argireline) for expression lines. Every peptide below rests on limited evidence, so "best" means best-tested, not proven.

When shopping for skin care products containing peptides, check the INCI list for these names, since brand trade names hide the actual peptide. A retinoid still has stronger evidence than any peptide; see peptides vs retinol.

What are the 4 classes of peptide ingredients in skincare?

Signal, carrier, neurotransmitter-inhibiting and enzyme-inhibitor peptides. The grouping reflects each peptide's proposed mechanism.

The standard classification comes from a widely cited review by Gorouhi and Maibach at UC San Francisco (about 187 citations on Semantic Scholar). It sorts topical anti-aging peptides into signal peptides, enzyme-inhibitor peptides, neurotransmitter-inhibitor peptides and carrier peptides (Gorouhi & Maibach, 2009). An earlier dermatology review used 3 groups and left out enzyme inhibitors (Lupo & Cole, 2007). A 2025 review of 102 commercial peptides added categories such as pigmentation, microbiome and antioxidant peptides (van Walraven et al., 2025).

INCI names and functions were checked against the EU CosIng database. Every peptide on this page is classified there as skin conditioning (some are also listed as humectant). None has a regulatory "anti-wrinkle" function (CosIng).

What are signal peptides?

Signal peptides are mostly matrikines: short sequences copied from pieces of collagen or other matrix proteins. When skin matrix breaks down, these fragments are thought to tell fibroblasts to rebuild. A signal peptide imitates that message.

Palmitoyl pentapeptide-4 (Matrixyl)

What it is: The sequence KTTKS (lysine-threonine-threonine-lysine-serine), a fragment of type I procollagen, with a palmitic acid tail attached to help it get through the skin's lipids. Sold as Matrixyl and sometimes listed under its older name, palmitoyl pentapeptide-3. CosIng: PALMITOYL PENTAPEPTIDE-4, skin conditioning – miscellaneous.

Human evidence: - The anchor trial: 93 Caucasian women aged 35–55. 12 weeks, double-blind, placebo-controlled, split-face, randomized left/right. The moisturizer contained just 3 ppm pal-KTTKS. It significantly improved wrinkles and fine lines vs placebo by both image analysis and expert graders, and was well tolerated (Robinson et al., 2005). Run by Procter & Gamble. About 180 citations, but we found no independent replication at this size. - A small head-to-head: 21 Indonesian women aged 26–55. 8 weeks, double-blind, randomized into palmitoyl pentapeptide-4, acetyl hexapeptide-3 (Argireline) or placebo for crow's feet. The pentapeptide group looked better than both. The authors call it an "initial study" needing more participants and a longer duration (Aruan et al., 2023). No conflicts declared. Evidence: early / preliminary.

Label: Limited. Two human RCTs point the same way, but one is manufacturer-run and the other has about 7 people per arm.

What we cut: You'll see "reduces wrinkle depth by 45%" and "increases skin thickness by 12%" in Matrixyl marketing. We could not find those figures in any PubMed- or Europe PMC-indexed study, so we don't repeat them.

Matrixyl 3000: palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7

What it is: A blend of Pal-GHK (palmitoyl tripeptide-1, the copper-free cousin of GHK-Cu) and Pal-GQPR (palmitoyl tetrapeptide-7). CosIng lists both as skin conditioning.

Penetration evidence (rare, and recent): A 2026 study from the University of Nottingham and Boots/No7 applied a Matrixyl 3000 serum to 3 healthy women for 0.5–5 hours, then used tape stripping and high-resolution mass spectrometry (OrbiSIMS). Both peptides were detected throughout every layer of the stratum corneum, decreasing with depth. They traveled between cells rather than through them, and longer contact didn't push them deeper (Trzaska et al., 2026). Evidence: early / preliminary. Note: n=3, two co-authors are employees of No7/Boots (a skincare brand), and the paper is so new it has no citations yet. It shows the peptides get into the outer barrier. It does not show they reach the living dermis, where fibroblasts are.

Efficacy evidence: We found no indexed randomized trial of Matrixyl 3000 on its own. Readers in skincare communities report mixed results, with some noticing nothing from Matrixyl 3000. That's anecdote, not evidence, but it matches the thin data.

Other signal peptides

• Tripeptide-10 citrulline is a "decorin-like" tetrapeptide. In lab tests it made collagen fibrils thinner and more uniform (Puig et al., 2008; developed by the supplier, Lipotec). In a 60-day randomized study of 24 volunteers (4 arms, so about 6 per arm), it improved skin microtopography measures alone and with acetyl hexapeptide-3 (Raikou et al., 2017). Evidence: early / preliminary.
• Palmitoyl tripeptide-5 appears in multi-ingredient microneedle patches (see below), so its own effect can't be isolated.

What are carrier peptides?

Carrier peptides deliver trace metals such as copper to the skin. GHK-Cu is the main example.

Carrier peptides deliver trace elements. The main example is GHK-Cu (copper tripeptide-1). Copper is a cofactor for enzymes such as lysyl oxidase, which cross-links collagen. In fibroblast culture, GHK-Cu raised collagen synthesis at concentrations down to 1 nanomolar (Maquart et al., 1988). In rat wounds, injections increased collagen and glycosaminoglycans (Maquart et al., 1993).

An independent 2025 review found "a surprising absence of clinical studies" for topical GHK-Cu (Mortazavi et al., 2025; a narrative review with about 12 citations so far. Evidence: limited.). In lab tests, almost no intact peptide crossed intact human skin in 9 hours without microneedle pretreatment (Li et al., 2015). Evidence: lab/animal strong; human limited. For the full picture, including the unpublished facial studies and how GHK-Cu interacts with vitamin C, read our copper peptides guide.

What are neurotransmitter-inhibiting peptides?

Neurotransmitter-inhibiting peptides aim at dynamic wrinkles: the lines that come from repeated muscle movement, such as crow's feet and forehead lines. Botulinum toxin works by cutting SNAP-25, a protein in the SNARE complex that lets nerve endings release acetylcholine. These peptides instead mimic part of SNAP-25 and compete with it, which in lab models weakens SNARE assembly.

Acetyl hexapeptide-8 (Argireline)

What it is: Ac-EEMQRR-NH₂, a 6-amino-acid fragment from the N-terminal end of SNAP-25. The INCI name is acetyl hexapeptide-8. Many products and papers still use the older name, acetyl hexapeptide-3. CosIng lists it as humectant and skin conditioning.

Human evidence: - Developer study: an oil-in-water emulsion with 10% hexapeptide reduced wrinkle depth by up to 30% after 30 days in healthy women. In lab tests it inhibited neurotransmitter release with potency similar to botulinum toxin A but much lower efficacy (Blanes-Mira et al., 2002). The abstract doesn't report sample size or a placebo arm, and the authors include the supplier's team. About 183 citations. - Independent RCT: 60 Chinese adults randomized 3:1 to Argireline or placebo, applied twice daily to the eye area for 4 weeks. Total anti-wrinkle efficacy on subjective grading was 48.9% vs 0% for placebo, and silicone-replica roughness measures dropped significantly only with Argireline (Wang et al., 2013). Concentration isn't stated in the abstract. - Small trials: In 24 volunteers over 60 days, acetyl hexapeptide-3 improved microtopography and lowered transepidermal water loss (TEWL) (Raikou et al., 2017). In the 21-woman Indonesian trial, it did worse than palmitoyl pentapeptide-4 (Aruan et al., 2023). - Animal: In D-galactose-aged mice, 6 weeks of topical Argireline increased type I collagen fibers (Wang et al., 2013, J Cosmet Laser Ther). Lab/animal only.

For the full picture, see what Argireline does and Argireline before and after: what the trials show.

Label: Limited to moderate. Several small human trials point the same way, and one of them is a reasonably sized independent RCT.

The penetration problem: A 2025 review concluded that because acetyl hexapeptide-8 is hydrophilic and relatively large, "the ability of AH-8 to reach neuromuscular junctions remains uncertain" (Zdrada-Nowak et al., 2025). In porcine skin, water-rich emulsions (oil-in-water and water-in-oil-in-water) delivered more of it into the stratum corneum than an oil-rich one (Hoppel et al., 2015). A Singapore team called its permeation "poor" because it carries charge (zwitterionic) and is large, and it is building modified versions to fix that (Lim et al., 2018). So the measured wrinkle effects may come from hydration and surface effects rather than relaxing muscles. We don't know yet.

Acetyl octapeptide-3 (SNAP-8)

What it is: An 8-amino-acid extension of the Argireline sequence, marketed as SNAP-8. CosIng: ACETYL OCTAPEPTIDE-3, humectant, skin conditioning.

Human evidence: We found no indexed RCT of a SNAP-8 cream on its own. It appears only in multi-ingredient microneedle patches: - 24 subjects, a dissolving hyaluronic-acid microneedle patch with acetyl octapeptide-3 plus a vitamin C derivative and other actives, applied overnight to one eye area with placebo on the other, for 28 days. Wrinkles, TEWL and elasticity improved vs placebo (Shin et al., 2024; authors employed by the patch maker). - A 12-week open study of HA microneedle patches with acetyl octapeptide-3, palmitoyl tripeptide-5 and other actives reported a 25.8% decrease in fine lines and a 14.2% increase in dermal density (Avcil et al., 2020; industry-affiliated, sample size not in the abstract).

Label: Early / preliminary, and these results can't be attributed to SNAP-8 itself.

Dipeptide diaminobutyroyl benzylamide diacetate ("snake peptide")

A synthetic dipeptide marketed as mimicking a snake-venom peptide. Its only indexed human data come from a L'Oréal serum that also contained acetyl hexapeptide-8, gluconolactone and niacinamide. Across 2 open studies (n=50 and n=42), static-wrinkle scores improved by 35%–69% and dynamic-wrinkle scores by 10%–13% over 12 weeks (Zhu et al., 2026; L'Oréal authors, no placebo described in the abstract). Evidence: limited; multi-ingredient, manufacturer-run.

What are enzyme-inhibitor peptides?

Enzyme-inhibitor peptides are meant to slow the enzymes that break down collagen and elastin or make pigment. Human evidence for them is sparse.

Enzyme-inhibitor peptides target the enzymes that break the matrix down: matrix metalloproteinases (MMPs), elastase and, for pigmentation, tyrosinase. Gorouhi and Maibach included soybean and rice-derived peptides here (Gorouhi & Maibach, 2009). The modern evidence is almost all test-tube work. For example, GHK-Cu in liposomes inhibited elastase by about 49% in vitro (Dymek et al., 2023). A 2025 review lists enzyme inhibition among the claimed activities of commercial peptides but describes the support as mostly in vitro and ex vivo (van Walraven et al., 2025). Evidence: lab only.

Do peptides actually penetrate the skin?

Whether peptides penetrate the skin is the question readers ask most often. Many people notice that peptide molecules seem too big to get through skin and want to know if they are paying for something that sits on the surface.

The barrier problem. The stratum corneum favors small, moderately oily molecules. Peptides are usually larger and water-loving. GHK-Cu's log D is about −2.4 (Badenhorst et al., 2016), and Argireline is a charged hexapeptide (Lim et al., 2018).

What has been measured:

How formulators try to help: Attaching fatty acids (the "palmitoyl" in many names), liposomes and nanocarriers, and physically bypassing the barrier with microneedles (Zhang et al., 2023). Microneedles have the clearest data: they took GHK-Cu from almost no permeation to measurable permeation (Li et al., 2015).

Do they survive once they're in? Skin is full of proteases (protein-cutting enzymes). In human skin homogenate, pal-KTTKS and two newer test peptides stayed stable for up to 8 hours (Errante et al., 2021). That is encouraging for the palmitoylated signal peptides, but it is one lab model.

For the full breakdown of penetration studies and delivery tricks, see do peptides absorb into skin?

Our read: Some peptides demonstrably get into the stratum corneum, and the signal peptides act at very low concentrations in cells. But no study we found has measured a commercial peptide serum delivering intact peptide to the dermis of intact facial skin in people. The human trials show some effect, and the mechanism behind it is still uncertain.

How do you use skin care products containing peptides?

Add one peptide product at a time, use it consistently for 8 to 12 weeks, and keep sunscreen and a retinoid as the core of an anti-aging routine.

• Concentration claims: The best-supported Matrixyl trial used 3 ppm (Robinson et al., 2005), and Argireline's developer study used 10% (Blanes-Mira et al., 2002). No human dose-response data say more is better for either.
• Vehicle matters: Water-rich serums and emulsions delivered Argireline better than oil-rich ones in porcine skin (Hoppel et al., 2015).
• Combining peptides: The only indexed combination trial (tripeptide-10 citrulline plus acetyl hexapeptide-3) found some added benefit but couldn't explain the synergy (Raikou et al., 2017). Stacking signal and neurotransmitter peptides is reasonable but not proven.
• With other actives: Peptides pair well with niacinamide. Copper peptides are the exception that needs spacing from low-pH vitamin C, as explained in our copper peptides guide. For a complete day-and-night order, see our skincare protocol.
• Barrier first: If your skin stings or flakes, fix that before you add actives. See repairing your skin barrier.
• Give it 8–12 weeks: The best RCTs ran 4–12 weeks (Wang et al., 2013; Robinson et al., 2005).

Are peptides better than retinoids?

No. Retinoids have much stronger human evidence, including a 24-week vehicle-controlled RCT of 0.4% retinol in 36 older adults (Kafi et al., 2007); peptides are a gentler, less proven option. For help deciding, see peptides vs retinol: which should you choose?

Are topical peptides the same as oral collagen peptides?

Collagen supplements are a different category: hydrolyzed collagen peptides you swallow, not signal peptides you apply to skin. The evidence and the questions differ, so we cover them separately in what the trials say about collagen supplements.

Where the evidence stops

• Most of the 102 commercial cosmetic peptides have only in vitro or ex vivo support (van Walraven et al., 2025).
• No independent replication of the Matrixyl trial at comparable size.
• No study shows topical Argireline or SNAP-8 reaching facial muscles in humans.
• No human dose-response data for any peptide.
• Very few head-to-head comparisons between peptide classes.

FAQ

Do peptides actually penetrate the skin? Some do, at least partway. Matrixyl 3000's two peptides were detected throughout the stratum corneum in volunteers (Trzaska et al., 2026). But intact GHK-Cu barely crossed intact skin in a lab test (Li et al., 2015), and Argireline's ability to reach muscle is uncertain (Zdrada-Nowak et al., 2025).

Is Argireline really topical Botox? No. It targets the same SNARE machinery in lab tests, with "much lower efficacy" than botulinum toxin (Blanes-Mira et al., 2002). Human trials show modest softening of lines over 4 weeks (Wang et al., 2013), and the effect isn't comparable to injections.

Matrixyl vs Matrixyl 3000: what's the difference? Matrixyl is palmitoyl pentapeptide-4 and has a 93-person RCT behind it (Robinson et al., 2005). Matrixyl 3000 is palmitoyl tripeptide-1 plus palmitoyl tetrapeptide-7. It has penetration data (Trzaska et al., 2026) but no indexed efficacy RCT that we could find.

Can you use multiple peptides together? Yes. They are low-irritation and work through different routes. One small RCT found an added benefit from combining a signal peptide with Argireline (Raikou et al., 2017), but synergy isn't proven.

Are peptides a substitute for retinol? Not on current evidence. Retinoids have far more controlled human data (Mukherjee et al., 2006). Peptides are a gentler add-on or a fallback if you can't tolerate retinoids.

How long do peptide serums take to work? Trials ran 4 to 12 weeks, so judge any peptide after at least 8–12 weeks of consistent use.

Go deeper

• Copper peptides (GHK-Cu): mechanism, absorption and layering
• Repairing your skin barrier
• A step-by-step skincare protocol
• Collagen supplements: what the evidence shows
• Do peptides absorb into skin? A closer look at penetration studies
• Matrixyl vs copper peptides: which has better evidence?
• What does Argireline do?
• Argireline vs Matrixyl
• Matrixyl and Matrixyl 3000: what the evidence shows

References

1. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009. Systematic-style review. https://pubmed.ncbi.nlm.nih.gov/19570099/
2. Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007. Review. https://pubmed.ncbi.nlm.nih.gov/18045359/
3. van Walraven N, et al. Bioactive peptides in cosmetic formulations: review of current in vitro and ex vivo evidence. Peptides. 2025. Review (102 peptides). https://pubmed.ncbi.nlm.nih.gov/40946970/
4. Robinson LR, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005. Split-face RCT, n=93, 12 weeks; P&G. https://pubmed.ncbi.nlm.nih.gov/18492182/
5. Aruan RR, et al. Double-blind, randomized trial on the effectiveness of acetylhexapeptide-3 cream and palmitoyl pentapeptide-4 cream for crow's feet. J Clin Aesthet Dermatol. 2023. RCT, n=21, 8 weeks. https://pubmed.ncbi.nlm.nih.gov/36909866/
6. Trzaska AH, et al. Permeation behaviour of cosmetic actives into the human stratum corneum. Int J Pharm. 2026. In vivo tape-strip, n=3; Boots/No7 co-authors. https://pubmed.ncbi.nlm.nih.gov/42790608/
7. Puig A, Antón JM, Mangues M. A new decorin-like tetrapeptide for optimal organization of collagen fibres. Int J Cosmet Sci. 2008. In vitro; Lipotec. https://pubmed.ncbi.nlm.nih.gov/18377618/
8. Raikou V, et al. The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. J Cosmet Dermatol. 2017. RCT, n=24, 60 days. https://pubmed.ncbi.nlm.nih.gov/28150423/
9. Maquart FX, Pickart L, et al. Stimulation of collagen synthesis in fibroblast cultures by GHK-Cu2+. FEBS Lett. 1988. In vitro. https://pubmed.ncbi.nlm.nih.gov/3169264/
10. Maquart FX, et al. In vivo stimulation of connective tissue accumulation by GHK-Cu2+ in rat experimental wounds. J Clin Invest. 1993. Animal. https://pubmed.ncbi.nlm.nih.gov/8227353/
11. Mortazavi SM, et al. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. Bioimpacts. 2025. Review. https://pubmed.ncbi.nlm.nih.gov/39963574/
12. Li H, et al. Microneedle-mediated delivery of copper peptide through skin. Pharm Res. 2015. In vitro + porcine. https://pubmed.ncbi.nlm.nih.gov/25690343/
13. Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011. In vitro. https://pubmed.ncbi.nlm.nih.gov/20721598/
14. Blanes-Mira C, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002. In vitro + clinical; n not reported in abstract. https://pubmed.ncbi.nlm.nih.gov/18498523/
15. Wang Y, et al. The anti-wrinkle efficacy of argireline in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013. RCT, n=60, 4 weeks. https://pubmed.ncbi.nlm.nih.gov/23417317/
16. Wang Y, et al. The anti-wrinkle efficacy of Argireline. J Cosmet Laser Ther. 2013. Animal (aged mice), 6 weeks. https://pubmed.ncbi.nlm.nih.gov/23464592/
17. Zdrada-Nowak J, et al. Acetyl hexapeptide-8 in cosmeceuticals: a review of skin permeability and efficacy. Int J Mol Sci. 2025. Review. https://pubmed.ncbi.nlm.nih.gov/40565185/
18. Hoppel M, et al. Topical delivery of acetyl hexapeptide-8 from different emulsions. Eur J Pharm Sci. 2015. Porcine skin, in vitro. https://pubmed.ncbi.nlm.nih.gov/25497319/
19. Lim SH, et al. Enhanced skin permeation of anti-wrinkle peptides via molecular modification. Sci Rep. 2018. In vitro. https://pubmed.ncbi.nlm.nih.gov/29371611/
20. Shin JY, et al. Clinical safety and efficacy evaluation of a dissolving microneedle patch having dual anti-wrinkle effects. Ann Dermatol. 2024. Split-eye placebo-controlled, n=24, 28 days; manufacturer authors. https://pubmed.ncbi.nlm.nih.gov/39082657/
21. Avcil M, et al. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: a monocentric clinical study. J Cosmet Dermatol. 2020. Open-label, 12 weeks; industry-affiliated. https://pubmed.ncbi.nlm.nih.gov/31134751/
22. Zhu M, et al. The effect of a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture. Int J Cosmet Sci. 2026. Ex vivo + 2 clinical studies (n=50, n=42), 12 weeks; L'Oréal. https://pubmed.ncbi.nlm.nih.gov/41668671/
23. Dymek M, et al. Liposomes as carriers of GHK-Cu tripeptide for cosmetic application. Pharmaceutics. 2023. In vitro. https://pubmed.ncbi.nlm.nih.gov/37896245/
24. Badenhorst T, Svirskis D, Wu Z. Physicochemical characterization of native GHK tripeptide. Pharm Dev Technol. 2016. Lab. https://pubmed.ncbi.nlm.nih.gov/25384620/
25. Zhang T, et al. Peptide-containing nanoformulations: skin barrier penetration and activity contribution. Adv Drug Deliv Rev. 2023. Review. https://pubmed.ncbi.nlm.nih.gov/37951358/
26. Errante F, et al. Susceptibility of cosmeceutical peptides to proteases activity. J Pharm Biomed Anal. 2021. Lab (skin homogenate). https://pubmed.ncbi.nlm.nih.gov/33281001/
27. Kafi R, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007. RCT, n=36, 24 weeks. https://pubmed.ncbi.nlm.nih.gov/17515510/
28. Mukherjee S, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006. Review. https://pubmed.ncbi.nlm.nih.gov/18046911/
29. European Commission CosIng database: entries for PALMITOYL PENTAPEPTIDE-4, PALMITOYL TRIPEPTIDE-1, PALMITOYL TETRAPEPTIDE-7, PALMITOYL TRIPEPTIDE-5, TRIPEPTIDE-10 CITRULLINE, COPPER TRIPEPTIDE-1, ACETYL HEXAPEPTIDE-8, ACETYL OCTAPEPTIDE-3, DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE. https://ec.europa.eu/growth/tools-databases/cosing/

Disclosure: This article contains no affiliate links. It summarizes published research for general education and is not medical advice. Talk to a dermatologist or other clinician before starting prescription treatments or if you have a skin condition, allergy, or are pregnant.

For educational purposes only; not medical advice. See our disclaimer and research method.